Fluocinolone Acetonide NDC 70752-159

NDC codes

FDA NDC Directory

Product NDC (as listed)70752-159Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70752-0159Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70752-159-20	70752015920	1 BOTTLE in 1 CARTON (70752-159-20) / 20 mL in 1 BOTTLEMarketed from Apr 2, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fluocinolone Acetonide
Generic name (nonproprietary): fluocinolone acetonide
Active ingredients: Fluocinolone acetonide — .11 mg/mL
Dosage form: Oil
Route: Auricular (Otic)
Labeler: Quagen Pharmaceuticals LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212762
Marketing start: Apr 2, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 70752-159_c2b257ee-da2e-4af6-908a-aeb4838e698eSPL ID c2b257ee-da2e-4af6-908a-aeb4838e698eSPL set ID 2bcea813-d629-42c5-8953-fa231b4cbf58RxCUI 1191299UNII 0CD5FD6S2M
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N470752015920 followed by a unit qualifier and the quantity

Package 70752-0159-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 26, 2023.

Indications (excerpt from the label)

INDICATION AND USAGE Fluocinolone acetonide oil, 0.01% is a low to medium potency corticosteroid indicated for the treatment of chronic eczematous external otitis in adults and pediatric patients 2 years and older.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 212762

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212762
Product	Strength	Form · route	Labeler	Product NDC
Fluocinolone Acetonide	Fluocinolone acetonide .11 mg/mL	OilAuricular (Otic)	Bryant Ranch Prepack	71335-2879
Fluocinolone Acetonide	Fluocinolone acetonide .11 mg/mL	OilAuricular (Otic)	Bryant Ranch Prepack	72162-2320